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CHAPTER 1: BACKGROUND
I. Introduction
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the
United States, and coronary heart disease, a primary type of CVD, kills more than 385,000
people annually. A frequent result of coronary heart disease is myocardial ischemia, defined as
reduced coronary blood flow. If blood flow is not restored within 15-20 minutes, cardiac
myocyte death begins, which leads to a myocardial infarction (MI) (Thygesen et al., 2007). As
shown in Figure 1 below, although acute deaths from MI have significantly decreased over the
past several decades, mortality and hospitalization rates due to post-MI heart failure have
increased dramatically (Nahrendorf et al., 2010).

Figure 1: Coronary heart disease statistics. A, Deaths per 100 000 population for coronary heart
disease in men, ages 35 to 74 years, United States, 1970 to 2005. B, Deaths due to heart failure,
United States, 1970 to 2005. C, Hospitalizations per 100 000 population for heart failure, age ≥
65 years, United States, 1971 to 2006. Adapted from National Heart, Lung, and Blood Institute
Fact Book 2008. (Nahrendorf et al. Circulation 2010)
Post-MI heart failure is due to cardiac remodeling, a complex process in both infarct and
non-infarct zones, which induces changes in cardiac structure and function (Olivetti et al., 1990;
Cohn et al., 2000; Zornoff et al., 2009). In the infarct zone dead and dying cardiac myocytes
release numerous cytokines and matrix metalloproteinase (MMPs) which facilitate the influx of
inflammatory cells, such as neutrophils and monocytes, and degrade the existing extracellular
matrix (Lindsey and Zamilpa, 2012). Cytokines along with MMPs from the dead myocytes also
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play critical roles in the repair process by stimulating cardiac fibroblast (CF) chemotaxis and
promoting CF infiltration into the infarct region (Sutton and Sharpe, 2000). Infiltration and
proliferation of CF and their differentiation into myofibroblasts are critical for the deposition of
collagen to maintain scar thickness and stability (Holmes et al., 1997). Collagen is needed in the
infarct zone to maintain the integrity of the left ventricular (LV) wall due to wall thinning
following myocyte death, or heart rupture can occur (Fang et al., 2008).
Infarct expansion is the process in which wall thinning spreads into the border zone and
remote regions and this leads to LV dilatation and progressive adverse cardiac remodeling
(Boyle and Weisman, 1993). Abnormal proliferation and differentiation of CF and excess
collagen deposition in the remote zone play pathological roles in LV remodeling after MI (Booz
and Baker, 1995). Deposition of collagen in the non-infarcted myocardium is associated with
increased myocardial stiffness and impaired diastolic heart function (Litwin et al., 1991).
Prolonged adverse remodeling after MI contributes significantly to LV dilation and dysfunction,
which can lead to heart failure (Pfeffer and Braunwald, 1990). The three primary determinants
in the development of post-MI heart failure are the size of the infarct, the wound healing
response that occurs in the days and weeks after the MI, and chronic remodeling of the infarct
and the remote zones (Kempf et al., 2012).
II. Immune cells and post-MI remodeling
Immune cells such as neutrophils, macrophages, dendritic cells, and T cells are all
involved in post-MI remodeling (Nahrendorf et al., 2010). Neutrophils, whose functions include
proteolytic enzyme secretion and reactive oxygen species formation, penetrate into the infarct
region within 2-3 hours after an MI, and peak at about one day post-MI (Nahrendorf et al.,
2010). Then macrophages derived from circulating monocytes infiltrate into the same region.
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One current theory regarding the subsets and the role of macrophage in post-MI remodeling is
shown in Figure 2:

Figure 2: Biphasic monocyte response after myocardial infarction in the mouse. Time course of
monocyte subset recruitment and their function depicted in the lower panel are adapted from
Nahrendorf/Swirski et al. J Exp Med 2007. PMN: neutrophil, M : macrophage, ECM:
extracellular matrix.
In mice, monocytes exist as two different subsets: pro-inflammatory M1 (Ly-6Chigh) and
anti-inflammatory M2 (Ly-6Clow). These subsets of mouse monocytes are quite similar to human
monocytes in which CD16- monocytes resemble mouse Ly-6Chigh monocytes, and CD16+
monocytes resemble mouse Ly-6Clow monocytes (Nahrendorf et al., 2010). Peripheral Ly-6Chigh
monocytes are recruited to the ischemic region within hours after MI occurs, with chemokine (CC motif) ligand 2 (CCL2) and its receptor CCR2 playing important roles (Nahrendorf et al.,
2010). Following infiltration these Ly-6Chigh monocytes differentiate into M1 macrophages,
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which phagocytize dead myocytes and neutrophils (Nahrendorf et al., 2010), and contribute to
inflammation by producing inflammatory cytokines, such as IL-1β, IL-6, and TNF- (Mosser,
2003; Fujiu and Nagai, 2013; van Nieuwenhoven and Turner, 2013). M1 macrophages also
express inducible nitric oxide synthase (iNOS) which uses arginine as a substrate to synthesize
NO (Weisser et al., 2013). Although M1 macrophages are critical in post-MI healing, it has been
shown that the peak level of M1 macrophages is negatively associated with myocardium salvage
in MI patients (Tsujioka et al., 2009).
The transition from inflammation to the healing process in the post-MI heart is thought to
be associated with the transition from M1 to M2 macrophages (Anzai, 2013). M2 macrophages
are differentiated from Ly-6Clow monocytes, which are recruited by fractalkine and CX3CR1
receptor (Nahrendorf et al., 2010). M2 macrophages secrete IL-4, TGF, and IL-10, which can
inhibit production of pro-inflammatory cytokines (Lambert et al., 2008). M2 macrophages also
exhibit upregulation of constitutively expressed arginase 1, which competes with iNOS for
arginine, by catabolizing it to ornithine and downstream polyamines and proline (Mosser, 2003;
Weisser et al., 2013), which have been implicated in cell proliferation and collagen synthesis,
respectively (Morris, 2009), although a role for arginase in post-MI remodeling has not been
determined. It has been demonstrated that M2 macrophages promote ECM reconstruction,
fibroblast proliferation and angiogenesis (Sunderkotter et al., 1991; Cao et al., 2000; Song et al.,
2000). Total macrophage infiltration in the infarct zone dramatically increases by day 4, then
decreases by day 7 (Yang et al., 2002; Naresh et al., 2012), with evidence that M1 macrophages
peak ~ day 3 and M2 macrophages peaking at 5-7 days post-MI (Nahrendorf et al., 2010).
Extracellular matrix (ECM) destruction is initiated via the initial production of MMPs by
neutrophils and myocytes (Lindsey and Zamilpa, 2012). The MMP family can be divided into
several classes based on substrate specificity: collagenases and gelatinases. Collagenases, such
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as MMP-1 and 8, degrade fibrillar collagen types I, II and III, whereas gelatinases, MMP-2 and
9, degrade ECM components of the basement membrane including types IV and V collagen,
fibronectin, and elastin (Romanic et al., 2001). There is evidence that neutrophils can secret
MMP-8 and 9, and myocytes express MMP-2, 3, 7, 9 and 14 (Lindsey and Zamilpa, 2012).
Neutrophil-derived MMP-9 degrades the extracellular matrix and promotes further leukocyte
infiltration into the infarct area (Ma et al., 2013). Macrophages also promote ECM destruction
(Lambert et al., 2008) by secreting matrix metalloproteinases (MMP) -1, 2 and 9 (Aikawa et al.,
2001; Soumyarani and Jayakumari, 2012). Although increased MMP activity is a necessary
aspect of post-MI healing and repair excessive activation can be detrimental, genetic deletion of
MMP-9 has been reported to reduce LV dilation in a mouse MI model (Ducharme et al., 2000).
MMP-2 KO mice have less post-MI ventricular rupture and delayed LV adverse remodeling due
to less macrophage infiltration (Matsumura et al., 2005). Excess infiltration of inflammatory
cells and activation of MMP-8 and -9 is thought to contribute to post-MI heart rupture in humans
(van den Borne et al., 2009). The amount of MMP activation and its timing is critical as evident
from the paradoxical observation that overexpression of MMP-9 in macrophages is associated
with decreased inflammatory cytokine expression and improved cardiac function in the post-MI
heart (Lindsey and Zamilpa, 2012; Zamilpa et al., 2012).
III. Cardiac fibroblasts and post-MI remodeling
CF play important roles in inflammation and MMPs secretion just as macrophages do.
However, CF have one more critical function which is the production of new ECM in the form of
collagen. These roles of CF in post-MI remodeling are shown in Figure 3.
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Figure 3: Cardiac fibroblasts in responding to proinflammatory and profibrotic signals. DAMPs:
damage-associated molecular patterns; CXCL: The chemokine (C-X-C motif) ligand; CCN2:
Connective tissue growth factor; PDGF: platelet-derived growth factor; bFGF: basic fibroblast
growth factor. (van Nieuwenhoven and Turner, 2013)
The inflammatory environment plays a very important effect on CF function. Proinflammatory cytokines, such as IL-1and TNF- which are produced by both M1
macrophages and CF, can increase CF MMP secretion and activity, and inhibit CF collagen
production (Chen and Frangogiannis, 2013; Rhaleb et al., 2013; Turner, 2014). In contrast the
production of TGF by M2 macrophages induces CF proliferation and differentiation to
myofibroblasts (Desmouliere et al., 1993), which are responsible for collagen deposition (Porter
and Turner, 2009). CF can also secrete IL-6 which promotes collagen expression in cultured CF
(Ma et al., 2012). Similar to macrophages, CF can also secrete MMPs, such as MMP-2 and 9
(Aikawa et al., 2001; Xie et al., 2003; Soumyarani and Jayakumari, 2012), which degrade the
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ECM and stimulate cardiac remodeling in the post-MI heart (Lindsey, 2004; Halade et al., 2013).
Collagen turnover in the heart is a dynamic process that involves both collagen synthesis and
degradation (Laurent, 1987), thus there is a fine balance between ECM degradation and collagen
production.
Myocardial infarction not only induces CF migration and proliferation in the infarct
region, but also in the remote zone (Chen and Frangogiannis, 2013). Activated macrophages
accumulate in the remote zone later than in the scar zone, and contribute to post-MI fibrosis
(Nian et al., 2004; Lee et al., 2012; Nahrendorf and Swirski, 2013). CF can also synthesize
connective tissue growth factor (CTGF), platelet-derived growth factor (PDGF), and basic
fibroblast growth factor (bFGF), which all exert pro-fibrotic effects in cardiac fibrosis (van
Nieuwenhoven and Turner, 2013). Excess collagen deposition into the remote zone of post-MI
heart has been shown to be detrimental to cardiac function (Litwin et al., 1991).
IV. Cardiac Adenosine A2AR and A2BR Receptors
Adenosine, a purine nucleoside, whose production increases during conditions of
hypoxia, ischemia, and inflammation, exerts its effects via four subtypes of adenosine receptors:
A1, A2A, A2B and A3 (Linden, 2005). All four subtypes are expressed in the heart, and the most
well-known effects of adenosine in the normal heart are bradycardia via A1 receptors, and
coronary vasodilation via A2AR and A2BR. The most well recognized effects of adenosine
receptors occur during conditions of reduced oxygen supply:demand. Stimulation of all four
subtypes of adenosine receptors decreases acute myocardial ischemia-reperfusion injury,
whereas receptor blockade or deletion does not exert any acute effects (Headrick and Lasley,
2009; McIntosh and Lasley, 2012).
Although adenosine A2BR and A2AR are expressed in cardiac myocytes, these two
receptors are more highly expressed in immune cells and CF (Dubey et al., 1998; Dubey et al.,
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2001; Chen et al., 2004; Kreckler et al., 2006; Hasko et al., 2008; Epperson et al., 2009; Wilson
et al., 2011; Ehrentraut et al., 2012; Zhang et al., 2013). A2BR are low affinity receptors and
A2AR are high affinity receptors (Bruns et al., 1986). Thus, higher affinity A2AR can be activated
under normal conditions, while low affinity A2BR require high levels of adenosine, such as
observed during stress and injury. It is well recognized that A2AR and A2BR both couple to Gs
proteins which in turn cause cAMP accumulation and activate downstream pathways in various
cell types (Varani et al., 2010). cAMP accumulation is associated with stimulation of cAMP
response element binding protein (CREB) activity, although other kinases can also phosphorylate
CREB (Shaywitz and Greenberg, 1999). cAMP is generally thought to be anti-inflammatory in
immune cells and anti-fibrotic in rat CF (Dubey et al., 2001; Ohta and Sitkovsky, 2001; Liu et
al., 2006; Liu et al., 2008; Yokoyama et al., 2008; Villarreal et al., 2009). A2BR can also couple
to Gq proteins resulting in stimulation of the PLC cascade (Varani et al., 2010). In contrast to the
Gs pathway, Gq coupling, including that induced by A2BR, is generally pro-inflammatory and
pro-fibrotic (Guarda et al., 1993; Brilla et al., 1994; Lijnen et al., 2001; Villarreal et al., 2009;
Feng et al., 2010; Wilson et al., 2011). In addition, both A2BR and A2AR increase extracellular
signal-regulated kinase 1/2 (ERK1/2) phosphorylation (Epperson et al., 2009; Villarreal et al.,
2009), which is associated with increased collagen synthesis in CF (Chintalgattu and Katwa,
2004; Liu et al., 2006; Gao et al., 2009).
V. Roles of A2AR and A2BR in inflammation
The anti-inflammatory role of A2AR has been recognized for years (Hasko et al., 2008;
Hasko and Pacher, 2008). In one of the first such reports, Huang et al. (Huang et al., 1997)
showed that inhibition of lymphocyte expansion was via A2AR stimulation. It was subsequently
reported that activation of A2AR with a highly selective agonist reduced liver damage and TNF-
production in a Concanavalin A (Con A)-induced liver injury mouse model, whereas genetic
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deletion of A2AR prolonged pro-inflammatory cytokine serum levels and exacerbated liver
damage (Ohta and Sitkovsky, 2001).

Pharmacological stimulation of A2AR increases the

survival rate in sepsis, effects which were lost in A2AR KO mice (Sullivan et al., 2004). Direct
control of immune cell function has also been observed. Kreckler et al. concluded that A2AR
suppressed the production of TNF in mouse peritoneal macrophages (Kreckler et al., 2006).
Another report indicated that A2AR was involved in anti-inflammatory cytokine IL-10 production
(Csoka et al., 2007).
The recognition of a low affinity A2 receptor subtype, the A2BR, led to numerous studies
on the role of this receptor during inflammation. Initial observations in A2BR KO mouse led to
the hypothesis that this receptor exerted an anti-inflammatory role (Yang et al., 2006), which was
supported by a report that A2BR could contribute to inhibition of macrophage TNF- production
(Kreckler et al., 2006). There is evidence that A2BR plays an inhibitory role in acute airway and
lung inflammation (Zhou et al., 2009; Schingnitz et al., 2010), and genetic deletion of A2BR has
been shown to increase mortality and inflammatory cytokine production in a mouse sepsis model
(Csoka et al., 2010). It has also been reported that A2BR has stimulatory effects on antiinflammatory M2 macrophage cytokine production (Csoka et al., 2012).
Although there is significant support that A2BR activation exerts anti-inflammatory
effects, there are an equal number of studies suggesting that A2BR stimulation is proinflammatory. A 2001 study by Chunn et al. showed that increased expression of the A2BR in
the lungs of adenosine deaminase (ADA)-deficient mice (ADA is responsible for adenosine
catabolism) in association with severe pulmonary inflammation and injury implied a proinflammatory role of this receptor in chronic inflammatory disease (Chunn et al., 2001). A
subsequent report indicated that that A2BR antagonism reduced airway reactivity and
inflammation in a mouse model of allergic pulmonary inflammation (Fan et al., 2003). There is

10
evidence that A2BR antagonists reduce elevations in pro-inflammatory cytokines as well as
mediators of airway remodeling induced by high adenosine levels in the lungs of ADA-deficient
mice (Sun et al., 2006). Selective blockade of A2BR has also been shown to decrease IL-19 from
human bronchial epithelial cells, resulting in downregulation of TNF- (Zhong et al., 2006).
Additional studies, using A2BR KO mice, suggested that A2BR could play an important role in
promoting chronic lung inflammatory processes including airway remodeling (Zaynagetdinov et
al., 2010). This conclusion was further strengthened by another group by using A2BR myeloid
specific KO mice (Belikoff et al., 2012). A2BR are also implicated in the stimulation of proinflammatory cytokines release in several cell types (Sitaraman et al., 2001; Rees et al., 2003;
Evans et al., 2006; Ryzhov et al., 2008a; Ryzhov et al., 2008b).
It appears that A2BR tend to be anti-inflammatory in acute model, but exert proinflammatory effects during chronic inflammation (Sun et al., 2006; Zhou et al., 2009;
Schingnitz et al., 2010; Zaynagetdinov et al., 2010). It is not entirely clear how A2BR have the
dual role. One possible explanation is that A2BR couple to both Gs and Gq proteins. Gs proteins
are generally considered to be anti-inflammatory, whereas Gq coupling is thought to be proinflammatory.

In fact there is evidence that A2BR-induced pro-inflammatory cytokine

production in several cell types, including immune cells and CF, is via Gq coupling (Ryzhov et
al., 2006; Feng et al., 2010; Wilson et al., 2011). It is possible that under chronic inflammation
A2BR may couple more efficiently to Gq or Gs may be downregulated.
VI. Adenosine A2 receptor subtypes and organ fibrosis
Adenosine A2AR and A2BR, which are highly expressed on fibroblasts, have been
reported to modulate fibrosis in several organs and alter collagen production in multiple types of
fibroblasts. Initial studies indicated that pharmacological stimulation of A2AR promoted wound
closure in mice (Montesinos et al., 1997), whereas A2AR blockade and deletion protected mice
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from bleomycin-induced dermal fibrosis (Chan et al., 2006a). Observations from the latter group
suggested that A2AR stimulation promoted hepatic cirrhosis (Chan et al., 2006b). Stimulation of
A2AR has also been shown to increase collagen production in dermal fibroblast and hepatic
stellate cells (Chan et al., 2006a; Chan et al., 2006b; Chan et al., 2013). Compared to A2AR,
there are much fewer studies in A2BR effects in organ fibrosis. Dai et al. indicated that A2BR
activation contributed to renal fibrosis by inducing IL-6 production (Dai et al., 2011). Findings
from another group suggested that A2BR exerted a pro-fibrotic role in pulmonary fibrosis (Sun et
al., 2006). In addition, the only study to date in non-cardiac fibroblasts stimulation of A2BR has
been reported to promotes collagen expression in corpus cavernosal fibroblasts (Wen et al.,
2010).
Despite numerous studies implicating A2AR and A2BR modulation of inflammation and
fibrosis, there have been few studies on the roles of these receptors in chronic cardiovascular
disease.

There have been no studies determining the role of A2AR in post-MI cardiac

remodeling, and results of A2BR studies in cardiac remodeling are inconsistent. Results from one
group implied that long term stimulation of A2BR in post-MI rats reduced cardiac remodeling and
cardiac fibrosis in the remote zone, but the nonselective adenosine receptor agonist 2chroloadenosine was not administered until 7-day post-MI (Wakeno et al., 2006). In contrast,
more recent observations in a mouse model indicated that a selective A2BR antagonist,
administered immediately after induction of MI and continuing for 14 days, increased scar
thickness and decreased LV remodeling (Toldo et al., 2012). Zhang et al. concluded that
selective antagonism of A2BR dramatically reduced cardiac fibrosis in an ischemia-reperfusion
rat model with similar drug treatment protocol as Wakeno et al. did in their experiments (Zhang
et al., 2013).
Although the roles of A2AR and A2BR in promoting fibrosis and collagen production in
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non-cardiac tissue are well recognized (Chan et al., 2006a; Chan et al., 2006b; Sun et al., 2006;
Chan et al., 2010; Dai et al., 2011; Karmouty-Quintana et al., 2012), all studies to date in rat CF
suggest that A2BR stimulation decreases collagen synthesis (Dubey et al., 1998; Chen et al.,
2004; Wakeno et al., 2006; Epperson et al., 2009; Villarreal et al., 2009). In contrast a recent
report indicated that A2BR stimulation increased collagen in human CF (Zhang et al., 2013). The
major limitation in all of these studies is the use of non-selective adenosine receptor agonists,
NECA and 2-chloroadenosine, despite the fact that CF express both A2BR and A2AR (Epperson
et al., 2009; Feng et al., 2010). It is well known that A2BR are low affinity receptors and A2AR
are high affinity receptors (Bruns et al., 1986). Thus the high doses (M) of these non-selective
adenosine receptor agonists that are required to activate A2BR also stimulate A2AR. There are
several reports that A2AR stimulation increases collagen production in fibroblasts and may
contribute to organ fibrosis, however the role of A2AR in CF functions is conflicting, despite the
use of a selective A2AR agonist (Dubey et al., 1997; Dubey et al., 2001; Chen et al., 2004).
The discrepancies in A2AR and A2BR effects on collagen production are similar to the
conflicting reports on the signaling effects induced by these receptors in CF. Although the nonselective agonist NECA increased cAMP in rat CF (Epperson et al., 2009) presumably via A2BR
activation, the same agonist has been reported to have no effect on the cAMP pathway in mouse
CF (Feng et al., 2010). Although increases in cAMP are typically associated with decreases in
collagen synthesis (Dubey et al., 2001; Liu et al., 2006; Liu et al., 2008; Yokoyama et al., 2008),
stimulation of A2AR, which increases cAMP accumulation exerts little, if any, effect on CF
collagen synthesis (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004; Epperson et al.,
2009). Phosphorylation of ERK has been implicated in CF collagen production (Chintalgattu
and Katwa, 2004; Liu et al., 2006; Gao et al., 2009), however the effects of A2BR on ERK
signaling are conflicting.

Epperson et al. showed that high dose NECA increased ERK
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activation in rat CF, but Feng et al. reported no effect of this agonist on ERK phosphorylation in
mouse CF (Feng et al., 2010). There are no reports of A2AR effects on ERK in CF.
The results of numerous studies in non-cardiac tissue indicate that adenosine A2BR can
exert anti-inflammatory effects, although there is significant evidence that in chronic models of
inflammation A2BR is pro-inflammatory. Pharmacological approaches examining the role of
A2BR in chronic models of myocardial ischemia are conflicting. Studies in cardiac fibroblasts,
which play both beneficial and deleterious effects in the post-MI heart, are also conflicting due to
the use of non-selective adenosine receptor agonists. To address these deficiencies we have
utilized the whole animal A2BR KO mouse in vivo, and a selective A2BR agonist in vitro.
VII. Main hypothesis and aims
The rationale of my study is shown in Figure 4. Macrophages and CF play primary roles
in the post-MI remodeling process and adenosine A2BR and A2AR are expressed on both cells
types. Although A2AR stimulation is an anti-inflammatory, current evidence suggests that this
receptor does not significantly alter CF collagen production, so we think that is unlikely this
receptor will alter adverse post-MI remodeling. On the other hand there is substanatial evidence
that A2BR is pro-inflammatory and pro-fibrotic during prolonged inflammation.
Figure 4: Schematic rationale of
this study. Mφ: Macrophage; ADO:
Adenosine; CF: Cardaic fibroblasts.
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Based on all of these facts and the three conflicting reports of A2BR in post-MI
remodeling, the main hypothesis of my research project was that deletion of A2BR reduces
adverse remodeling in post-MI mice, and selective activation of A2BR increases CF proinflammatory cytokine production and collagen expression. Two specific aims were tested:
1. To determine if deletion of A2BR alters post-MI remodeling.
2. To determine the functional roles of A2BR in murine CF.
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CHAPTER 2: DELETION OF ADENOSINE A2B RECEPTOR PROTECTS THE HEART
FROM ADVERSE POST-MI REMODELING
I. Rationale
Adenosine A2BR are highly expressed in immune cells and fibroblasts.

Significant

evidence has accumulated indicating that adenosine A2BR can exert acute anti-inflammatory
effects, however numerous additional reports indicate that A2BR contribute to inflammation and
fibrosis under chronic conditions.

Similar dual roles for A2BR may exist in the heart as

adenosine A2BR agonists have been shown to protect the acutely ischemic heart, but the chronic
post-MI heart is associated with significant inflammation and fibrosis. There have been few
reports of A2BR effects in the chronically ischemic heart, and these results have been conflicting.
The hypothesis of Aim 1 was that deletion of A2BR protected the post-MI mouse heart from
adverse remodeling and cardiac fibrosis.
II. Material and methods
A. Animals
All animals in this study were maintained and used in accordance with guidelines of the
National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Pub. No.
85-23, Revised 1996) and the Institutional Animal Care and Use Committee of Wayne State
University. Studies were performed in adult male C57BL/6 mice, 12-15 weeks of age WT
(Jackson Laboratories, Bar Harbor, ME) and A2BR KO mice. A2BR KO male mice were bred
from homozygous A2BR KO breeders on a C57BL/6 background, which were generous gift from
Dr. Stephen Tilley (University of North Carolina, Chapel Hill, NC).
B. Mouse MI model and heart slices preparation
Mice were anesthetized with isoflurane, intubated, and ventilated with room air using a
positive-pressure ventilator. A left thoracotomy was performed via the fourth intercostal space
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and the lungs retracted to expose the heart. After opening the pericardium, the main branch of
coronary artery was permanently ligated with a 7-0 silk suture near its origin between the
pulmonary outflow tract and the edge of the left atrium. Ligation was deemed successful when
the anterior wall of the LV turned pale. The lungs were inflated by increasing positive endexpiratory pressure, and the thoracotomy site was closed in layers. Animals were kept on a
heating pad until they recovered from anesthesia. Analgesia was achieved with bupivacaine (1.5
mg/kg, sc, prior to and at the conclusion of surgery) and ketoprofen (5 mg/kg, sc, 30 min prior to
surgery and 1-day postop).
C. RNA isolation and real-time quantitative PCR
Five day post-MI LV tissue was harvested, separated into infarct and remote zones based
on wall thickness and color, and RNA isolated and purified using the RNeasy Mini Kit
(QIAGEN, Valencia, CA). RNA quantity and quality were determined by spectrophotometry
with TE buffer under 260 and 280 nm wavelengths. All reagents used for reverse transcription
and real-time PCR were purchased from Life Technologies (Grand Island, NY).

Reverse

transcription was performed on 1 μg of total RNA, and gene expression was assayed with
TaqMan Universal PCR Master Mix and TaqMan labeled primers according to the
manufacturer's instructions (primer sequences were listed in Table 1). Real-time PCR was
conducted using the StepOnePlus Real-Time PCR System (Applied Biosystems, Carlsbad, CA).
Data were analyzed by the comparative 2−ΔCt method, and expression of the gene of interest was
calculated as a percentage of 18S ribosomal RNA (18S rRNA) expression.
Table 1: Sequences of primers used in Aim I
Gene
A2AR
A2BR
18S rRNA
TNF-α
MMP-9
Collagen-1
Collagen-3

Forward Primer Sequence 5’-3’
CACGCAGAGTTCCATCTTCA
GCTATGATCGTGGGCATTTT
GTAACCCGTTGAACCCCATT
GCCTCTTCTCATTCCTGC
GCGGAGATTGGGAACCAGCTGTA
5TGCCGTGACCTCAAGATGTG
GCGGAATTCCTGGACCAAAAGGTGATGCTG

Reverse Primer Sequence 5’-3’
GAGAGGATGATGGCCAGGTA
TTTCCGGAATCAATTCAAGC
CCATCCAATCGGTAGTAGCG
CTTCTCCTCCTTGTTGGG
GACGCGCCTGTGTACACCCACA
CACAAGCGTGCTGTAGGTGA
GCGGGATCCGAGGACCACGTTCCCCATTATG
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D. Heart harvest and sectioning
At 5 day or 28 day post-MI, the heart was arrested at diastole by injecting 10% KCl, and
then excised, weighed. After right ventricle removed, LV was weighed again to calculate
LV/total heart ratio. After injecting OCT into LV lumen, the LV was embedded into OCT in a
mold. The mold was put on a 60 mm petri dish pre-cooled by ~ 2 mL of liquid nitrogen. The
whole mold was put on a 100 mm petri dish sitting on dry ice, which contained adequate liquid
nitrogen. The sample was transferred and kept in a -80oC freezer after completely being frozen
to wait for sectioning.
Frozen samples were sectioned on a cryostat. Six 5 μm thick slices were cut every 900
m from base to apex. Every one of six heart slices was put on a different Super Frost Plus glass
slide. After the sectioning was done, all of the glass slides containing heart slices were kept in
the -80oC freezer.
E. Trichrome staining
The heart sample glass slide was taken out of the freezer, and allowed to sit in room
temperature (RT) for 20 min. Glass slide was washed in distilled water, and then fixed in
Bouin's solution for 24 hour at RT. Slides were rinsed under running tap water for 1 hr to
remove the yellow color.

Then slides was stained in Weigert's iron hematoxylin working

solution for 5 min, and rinsed under running tap water for 2 min again. After being washed in
distilled water, heart slices were stained in Biebrich scarlet-acid fuchsin solution for 15 minutes.
Then slides were washed again in distilled water. The hearts slides were then developed in
phosphomolybdic-phosphotungstic acid solution for 25 minutes. Slides were transferred directly
(without rinse) to aniline blue solution and stain for 15 minutes. After being differentiated in 1%
acetic acid solution for 2 minutes, heart slices were washed in distilled water for the last time,
and dehydrated very quickly through 2 changes of 95% alcohol and 2 changes of reagent alcohol
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and cleared in xylene. Finally, the heart slices were mounted with Permount. The staining
protocol was based on the protocol provided by the manufactory of Trichrome Staining Kit
(ScyTek, Logan, UT) with minor modifications.
F. Picrosirius red staining
The heart sample glass slide was taken out of the freezer, and allowed to sit in RT for 20
min. Glass slide was washed in distilled water, and then fixed in Bouin's solution for 24 hr at
RT. Slides were rinsed under running tap water for 1 hr to remove the yellow color. Glass slide
underwent several rehydration steps (100%, 95% and 70% alcohol, each for 10 seconds) and 1hr
picrosirius red staining. Then the slide was transferred and kept into acetic acid for 2 min. After
dehydration (70%, 95% and 100% alcohol, each for 10 seconds), slide was kept in xylene for 10
min, and then mounted with cover slide and Permount. The staining protocol was based on the
protocol provided by the manufactory of Picrosirius Red Staining Kit (ScyTek, Logan, UT).
G. Immunohistochemical staining for macrophage infiltration and myofibroblasts
The methods were similar to those described by Dr. Xiao-ping Yang’s group (Xu et al.,
2007). Frozen sections of the 5 day or 28 day post-MI hearts (5 μm) were fixed with acetone for
1 hr and rinsed in PBS (n = 5–6). They were pre-incubated with 0.3% hydrogen peroxide in PBS
to inhibit endogenous peroxidase activity and then incubated with the primary antibodies, CD68
and alpha smooth muscle actin antibodies (SMA).
1) Macrophage: Rat anti-mouse CD68 (a marker for mouse macrophages, 1:200; Serotec)
for 5-day and 28-day post-MI heart sections, supplemented with 5% of the species-respective
normal serum for 1 hr at room temperature. After washing with PBS, a secondary antibody was
applied for 30 min at room temperature, followed by avidin-biotin complex reagent (Vector
Labs, Burlingame, CA) for 30 min and 3-amino-9-ethylcarbazole (AEC, Vector Labs) for 30s to
1 min to visualize positive staining. The negative controls were processed in a similar fashion

19
except that they did not receive the primary antibody. Sections were counterstained with
hematoxylin.
2) SMA: 28-day sections were stained with mouse monoclonal antibody against αsmooth muscle actin (SMA, a marker for myofibroblasts, 1:50 dilution; Sigma, St. Louis, MO),
which was followed by a mouse to mouse staining kit ( M.O.M., Vector Labs) and then colored
with a peroxidase substrate kit, NovaRED (Vector Labs). Negative controls were processed in a
similar fashion in the absence of primary antibody.

Sections were counterstained with

hematoxylin.
H. Data collection
Morphological analysis
Infarct size was measured with images of Trichrome stained 28-day post-MI heart slices
taken by a Olympus E-10 DSLR camera. This analysis had been described by Takagawa et al.
(Takagawa et al., 2007). In brief, epicardial and endocardial infarct lengths and epicardial and
endocardial circumference of each of 7-8 heart slices from the same heart were traced manually
in the digital images and measured automatically by the SigmaScan Pro 4.0 software (Jandel
Scientific, San Rafael, CA). To define the infarct lengths, endocardial infarct length was taken
as the length of endocardial infarct scar surface that included >50% of the whole thickness of
myocardium and epicardial infarct length as the length of the transmural infarct region.
Epicardial infarct ratio was obtained by dividing the sum of epicardial infarct lengths from all
sections by the sum of epicardial circumferences from all sections. Endocardial infarct ratio was
calculated similarly. Infarct size derived from this approach was calculated as [(epicardial
infarct ratio + endocardial infarct ratio)/2] × 100.
Scar thickness and infarct expansion index were analyzed with the same Trichrome
staining images as in infarct size measurement. The middle heart slice which contained both scar
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and non-infarcted region was chosen. Scar and non-infarct wall thicknesses were measured by
the area of scar (or non-infarct) region divided by the endocardial scar (or non-infarct) length
(Lutgens et al., 1999).
To quantitate both the degree of left ventricular dilation and the degree of infarct wall
thinning, the following formula was devised: infarct expansion index (IE) equals to (LV cavity
area /Total LV area) x (non-infarcted wall thickness/infarcted thickness).

All of the

measurements were done by using by the SigmaScan Pro 4.0 software (Jandel Scientific, San
Rafael, CA).
Collagen content in remote zone of 28-day post-MI heart
Six 200X images were taken from the remote zone of Picrosirius red stained heart slices
with a camera attached Leica microscope. Areas containing blood vessels and perivascular
interstitial cells were excluded from collagen content quantification. Red pixel contents of
digitized images relative to total tissue area were counted using an open source analysis software
Image J (National Institute of Health). The average of collagen content of six regions represented
the overall collagen content.
Myocyte cross sectional area of 28-day post-MI heart
Three or four 200X images were taken from the remote zone of Picrosirius red stained
heart slices. Total 100-200 cross sectional area of myocytes were quantified. Then the numbers
were averaged.
Macrophage infiltration in 5-day scar and 28-day remote zones of post-MI heart
Six 400X images were taken from scar or remote zone of CD68 antibody stained heart
slices with the Leica microscope. Macrophages were quantified by counting the number of
reddish-brown cells taken equally distributed over six areas in the 5-day scar and 28-day remote
regions of post-MI heart. Average numbers were calculated and expressed as number per mm2.
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-Smooth muscle actin expression in 28-day remote zone of post-MI hearts
Percentage of the area of α-SMA positive fibroblasts was automatically detected by
computerized image analysis system (MicroSuite Biological imaging software; Olympus
America) on images taken with the Leica microscfOlyope at 400X. Mean values were calculated
from 12 regions of each heart.
I. Statistical analysis
Data are presented as means ± SE. All of the RT-PCR data and morphological and
histological measurements from the slice of post-MI hearts were analyzed by Student’s t-Tests.
Statistically significant differences were taken at p<0.05. The death and rupture rate were
analyzed by Fisher’s exact test.
III. Results
Table 2: Mortality, infarct size and other important parameters
Total number in each group
Number of deaths
Number of heart ruptures
Mortality (%)
Heart rupture rate (%)
Infarct Size (%)
LVW/BW (mg/10g)
Sham LVW/BW (mg/10g)
LW/BW (mg/10g)
Sham LW/BW (mg/10g)

WT
59
14
3
23.7
5.1
38.2 + 4.3
50.1 + 2.7*
38.0 + 1.7
64.2 + 3.8*
55.6 + 1.5

A2BR KO
62
19
6
30.6
9.7
33.3 + 4.4
51.6 + 3.0*
41.3 + 2.5
69.6 + 3.9*
59.8 + 2.9

The total number of animals included the animals used for 5-day post-MI gene expression and 5- and 28day post-MI morphological assays. Mortality was calculated as relative to the total animal number of postMI mice (RT-PCR, morphological and histological studies) in each group. Heart rupture rate was
calculated with the method as same as in mortality. LVW/BW (left ventricular weight/body weight) and
LW/BW (lung weight/body weight) were quantified from 28-day post-MI hearts. * p < 0.05 vs. sham
group of same genotype

Mortality, heart rupture rate, left ventricular weight (LVW)/body weight (BW), lung
weight (LW)/BW and infarct size are shown in Table 1. There was no significant difference in
death and heart rupture rates between the two groups. More importantly, our results indicated

22
that infarct size was not influenced by deletion of A2BR at 28-day post-MI. Although knocking
out of A2BR did not alter the LVW/BW and LW/BW ratios compared to WT MI group, the
values of these ratios in MI groups were significantly higher than the sham groups of each
genotype.

Figure 5: A2BR and A2AR gene expression in remote and scar zones of WT 5-day post-MI
hearts. Left side shows gene level in remote zone, and scar zone is shown in right side. Receptor
mRNA was normalized to 18S rRNA. Data are means ± SE, * p < 0.05 vs. in remote zone of the
same genotype (n > 5 for each genotype)
Both A2BR and A2AR are highly expressed in immune cells (Kreckler et al., 2006; Wilson
et al., 2011; Ehrentraut et al., 2012), which infiltrate the ischemic zone and mediate post-MI
inflammation, thus we examined the gene expression of these two adenosine receptor subtypes in
remote and scar zones of 5-day post-MI WT hearts. Our initial observations indicated that
GAPDH gene expression was increased in the scar region compared to the remote zone, thus we
used 18S ribosomal RNA as the housekeeping gene in the semi-quantitative RT-PCR assays. As
shown in Figure 5, scar zone A2BR mRNA levels were 2.8 fold higher than that in remote zone (p
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< 0.05). Scar zone A2AR message was decreased by > 40% in 4 of the 5 hearts (and was
unchanged in the fifth heart), but this effect did not reach statistical significance.
Figure 6: mRNA of TNF- and MMP-9 in
5-day post-MI hearts. A: TNF-MMP9. Left shows remote and right shows scar
in both panels. mRNA of TNF- and
MMP-9 was normalized to 18S rRNA.
Data are means ± SE, * p < 0.05 vs. WT
group in the same region (remote zone or
scar zone) (n > 5 for each genotype).

Figure 6 shows the effects of A2BR deletion on the gene expression of two proinflammatory cytokines, TNF- and MMP-9, which have been reported to contribute to cardiac
remodeling (Ducharme et al., 2000; Bradham et al., 2002). As shown in Figure 6A TNF- gene
levels in the 5-day post MI scar zone of WT hearts was 2.6-fold greater than in A2BR KO hearts
(p<0.05); there was no difference in the remote zone. There were no differences between the
groups in the expressions of other cytokines, such as IL-1β and IL-6 (data not shown). As
summarized in Figure 6B, matrix metalloproteinase 9 (MMP-9) gene expression in the scar zone
was 3.1-fold greater than in A2BR KO hearts (p<0.05).

One possible explanation for the
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differences in TNF- and MMP-9 expression in the A2BR KO hearts could be due to differences
in macrophage infiltration.
Figure 7: Effects of deleting A2BR in macrophage
infiltration in scar zone of 5-day post-MI hearts. 6
different regions images were taken from antiCD68 antibody stained sections under 400X
magnification. Data are means ± SE.

To identify if decreased TNF- and MMP-9 mRNA level was due to less macrophages
infiltration, we quantified macrophage number. Figure 7 indicates that there was no difference in
macrophage infiltration in 5-day post-MI scar zone between the two groups, based on
immunohistochemical staining with anti-CD86.
A

B

Figure 8: Collagen 1 and 3 gene expression in 5-day post-MI hearts. A: Collagen-1, B: Collagen3. mRNA of both collagen subtypes was normalized to 18S rRNA. Data are means ± SE, * p <
0.05 vs. WT group in the same region (remote zone or scar zone) (n = 5 for WT; n = 6 for A2BR
KO).
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Collagen synthesis is a necessary aspect of rebuilding the thinned wall in the infarct zone,
but excess collagen synthesis in the remote zone can lead to fibrosis and decreased cardiac
function (Jalil et al., 1989; Litwin et al., 1991; Fang et al., 2008). As shown in Figure 8
collagen-1 and collagen-3 gene expressions were significantly reduced in 5-day scar and remote
zones in A2BR KO hearts. Collagen-1 and collagen-3 gene expressions in the remote zone were
96% and 64%, respectively, greater in WT hearts compared with A2BR KO hearts (p < 0.05).
There were no differences between the groups in scar zone collagen isoform mRNAs.

Figure 9: A2BR effects in 28-day post-MI remodeling. Left Y axis: scar thickness; right Y axis:
infarct expansion index. Quantifications were achieved from Trichrome stained heart slices.
Data are means ± SE, * p < 0.05 vs. WT group (n = 11 for WT; n = 10 for A2BR KO).
Reduced post-MI inflammation and improved healing are associated with increased scar
thickness and reduced infarct expansion, and our findings on these morphological aspects of 28day post-MI hearts are illustrated in Figure 9. A2BR KO hearts exhibited significantly thicker
scars (0.36 + 0.03 mm vs. WT 0.29 + 0.02 mm) and less infarct expansion (1.57 + 0.19 vs. WT
2.81 + 0.38) compared with WT hearts (p < 0.05).
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Figure 10: A2BR effects in 28-day post-MI myocyte hypertrophy. Myocyte cross sectional area
was calculated by the mean of 100-200 randomly picked myocytes from Picrosirius red stained
heart slices. Images were taken under 200X magnification. Data are means ± SE. (n = 11 for
WT; n = 9 for A2BR KO).
We next examined another parameter, myocyte cross sectional area, to evaluate if
deletion of A2BR showed any effect in 28-day post-MI myocyte hypertrophy as shown in Figure
10. Our data indicated that there was no significant difference between the two genotypes.

Figure 11: Collagen content in
28-day post-MI heart remote
zone. 6 pictures were taken
from Picrosirius red stained
sections
with
200X
magnification. Data are means
± SE, * p < 0.05 vs. WT group
(n > 6 for each genotype).

Figure 11 demonstrates the collagen content in the remote zone based on Picrosirius red
staining. A2BR KO hearts (0.89 + 0.11% of the total area, p <0 .05) contained less collagen
compared to WT hearts (1.29 + 0.01% of the total area).
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To determine if the decreased remote zone collagen content in A2BR KO hearts was due
to differences in myofibroblast density, we assessed SMA expression, a marker of
myofibroblasts. As shown in Figure 12 there was no difference in remote zone SMA expression.

Figure 12: alpha smooth muscle actin
(SMA) expression in 28-day post-MI
remote region. Sections were stained
with anti-SMA antibody. 12 different
images were taken under 400X. Data are
means ± SE (n = 6 for WT; n = 5 for
A2BR KO).

It has been documented that activation of myofibroblasts is also influenced by
macrophages (Kong et al., 2014), so we next investigated macrophage infiltration in the remote
zone (Figure 13). Immunohistochemical detection of macrophages with anti-CD86 indicated
that deletion of A2BR was associated with significantly reduced macrophages in the remote zone
(304 + 38/mm2) compared to WT hearts (371 + 30/ mm2 in WT, p < 0.05).
Figure 13: A2BR effect in macrophage
infiltration of 28-day post-MI remote
zone. Staining and imaging conditions
were as same as in Fig. 6. Data are
means ± SE, * p < 0.05 vs. WT group
(n = 8 for each genotype).
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CHAPTER 3: SELECTIVE ACTIVATION OF A2BR PROMOTES COLLAGEN AND
PROINFLAMMATORY CYTOKINE PRODUCTION
I. Rational
Observations in the first Aim showed that deletion of A2BR reduced pro-inflammatory
cytokine gene level in the scar region at early stage of post-MI and decreased collagen deposition
in the remote zone at both 5 and 28-day post-MI, so we investigated these results at the cellular
level.

Cardiac fibroblasts, which make up a large portion of total cells in the heart, are

responsible for modulating ECM under both physiological and pathological conditions. The
function of CF is not only limited to collagen production, but also include cytokine, chemokine
and MMP secretion. Adenosine A2BR are highly expressed in CF, but the results of existing
studies determining the role of this receptor are conflicting. Given that A2AR are also expressed
on CF, a major limitation of these studies is the use of non-selective agonists. The purpose of
Aim 2 studies was to determine the effects of selective A2BR stimulation on CF function. The
hypothesis of Aim 2 was that selective activation of A2BR in murine CF promoted collagen and
pro-inflammatory cytokine production.
II. Materials and methods
A. Animals
Besides WT and A2BR KO mice which I already described in Aim I, we also used A2AR
KO mice. A2AR KO male mice were bred from homozygous A2AR KO breeders on a C57BL/6
background, which were generous gifts from Dr. Joel Linden (La Jolla Institute for Allergy and
Immunology, La Jolla, CA).
B. Drugs
The

A2AR

agonist

CGS-21680

(CGS),

the

non-selective

agonist

5'-N-

ethylcarboxamidoadenosine (NECA), and angiotensin II were purchased from Sigma-Aldrich
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(St. Louis, MO). The A2B receptor agonist BAY 60-6583 (BAY) was a kind gift from Dr.
Thomas Krahn (Bayer Healthcare, Wuppertal, Germany). The adenosine A2B receptor antagonist
N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8yl)phenoxy]-acetamide (MRS1754) and the PKA inhibitor H89 were purchased from TocrisCookson (Bristol, UK).

The MEK inhibitor U0126 was purchased from LC Laboratories

(Woburn, MA).
C. Cell culture
Hearts were excised from anesthetized (2~3% Isofluorane) and heparinized (500 units)
mice, placed in ice-cold saline, and mounted on a 20-gauge cannula. The hearts were perfused
with CF isolation buffer (in mM: 120 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 10 HEPES, 10
BDM, 5 NaHCO3, 20 Taurine, 11 Glucose, pyruvic acid 5, creatine 20). After the solution being
warmed up to 37 °C, pH value was adjusted to 7.2. Following 3.5 minutes of perfusion with
isolation buffer, the heart was perfused with isolation buffer containing collagenase B (0.5
mg/mL), collagenase D (0.5 mg/mL) and CaCl2 (50 µM). The heart was digested for 10~12
minutes until coronary perfusion pressure drop to ~30mmHg. The heart was removed from the
cannula, and minced in isolation buffer (with 50 µM calcium chloride and 10% FBS) using a
plastic pipette after cutting the atrial appendages. The CF was then be filtered through a mesh,
and settled by gravity in a 15 mL conical tube at room temperature for 15~20 min. The
supernate was collected into a new 15 mL conical tube and centrifuged at 1800 rpm for 3 min.
The pellet was resuspended in 5 mL complete Dulbecco’s modified Eagle’s medium (DMEM,
10 % FBS and 100 U/mL Penicillin/Streptomycin). CF were plated on a 60 mm diameter culture
dish in an incubator (37°C, 5% CO2). Culture medium was changed 1 hour and 24 hour after
plating to remove unattached cells.

CF were split into 5 dishes when reaching 70~80%

confluence. CF were starved by changing culture medium into serum free DMEM with or
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without ascorbic acid (0.05 mg/ml) when cells reaching 70~80% confluence after the first
passage. Drug treatments were start until 24 hour starvation.
D. Drug treatment protocols
Adenosine A2BR and A2AR receptor effects on ERK and CREB pathways (n > 4 for each
group) were assessed in serum-starved CF treated for 10 min with Veh, CGS (500 nM) and BAY
(500 nM). The selectivity of CGS and BAY as agonists of A2AR and A2BR, respectively, has
been well-established (Fredholm et al., 2001; Auchampach et al., 2009).

To determine if

adenosine receptor effects on CREB were PKA dependent, a subset of cells was pretreated with
the PKA inhibitor H89 (5 M) for 30 min prior to agonist treatments. CF isolated from A2A and
A2B KO mice were used to confirm that the signaling effects induced by CGS and BAY were
A2AR and A2BR-dependent, respectively.
Since A2AR and A2BR both increase cAMP in CF, an effect which is generally associated
with inhibition of collagen synthesis, we first evaluated the effects of selective A2AR and A2BR
agonists on TGF-induced collagen expression. Serum-starved CF were treated for 24 h with
TGF (10 ng/mL) alone or in the presence of CGS (500 nM), BAY (500 nM) or NECA (5 M)
(n > 4 for each group). Additional sets of CF (n > 6 for each group) were treated with adenosine
receptor agonists alone to assess their effects on collagen expression. Ascorbic acid (0.05
mg/ml) was added to the serum-free medium 24 h prior to the addition of agonists and during the
24 h treatments. In the final series of experiments, A2AR and A2BR agonist effects on collagen
synthesis were repeated in the presence of the MEK inhibitor, U0126 (10 M), or H89 (5 M).
The inhibitors were administered 30 min prior to the receptor agonists.
For pro-inflammatory cytokine gene expression study, serum-starved WT CF (n > 4 in
each group) were treated with vehicle (Veh, 0.01% DMSO), the A2AR agonist CGS (500 nM),
and the A2BR agonist BAY (500 nM) for 24 h. A schematic drug treatment protocol is shown in
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Figure 14.

Figure 14: Schematic CF drug treatment protocol.
E. Cell harvest and Western blotting
After agonist stimulations, culture dishes were washed with cold PBS prior to lysing with
NP-40 lysis buffer supplemented with 1% Triton and protease and phosphatase inhibitors. The
protease inhibitor cocktail (Sigma Chemical Co., St. Louis, MO) includes AEBSF (2 mM),
Aprotinin (0.3 μM), bestatin (130 μM), E-64 (14 mM), leupeptin (1 mM) and EDTA (1 mM).
The phosphatase inhibitor contains 100 mM sodium fluoride, 50 mM sodium pyrophosphate
decahydrate, 50 mM sodium orthovanadate, 100 mM β-glycerophosphate 100X concentrate
(Boston Bio, Ashland, MA). Lysates were sonicated, centrifuged at 10,000g (5 min, 4oC), and
the resulting supernatants were stored at -80oC. Denatured protein samples (10-15 g protein),
heated to 50oC for signaling studies and boiled for collagen-1 expression studies, were separated
using SDS-PAGE (10% resolving gels for kinases, 6% resolving gels for collagen-1). Following
transfer, nitrocellulose membranes were incubated with primary antibodies overnight (4°C with
gentle rocking) in TBST with 2.5% BSA for anti-phospho-kinase (pERK and pCREB) antibodies
and 1% milk for collagen-1 and tubulin. Membranes were then incubated with secondary
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antibodies for one hour at room temperature in TBST with 1% milk. Protein visualization was
performed using enhanced chemiluminescence and autoradiography. Phospho-kinase blots were
stripped and reprobed with antibodies for total ERK and CREB for normalization, while collagen
data were normalized to tubulin. Optical density of bands was quantified using UN-SCAN-IT
gel version 6.1 (Silk Scientific Inc, Orem, Utah).
F. RNA isolation and real-time quantitative PCR
For GPCR and cytokine gene expression assay, RNA was isolated from serum-starved
WT CF (n > 3) using the RNeasy Plus Mini Kit per manufacturer’s instructions (QIAGEN,
Valenica CA). The procedures of reverse transcription and RT-PCR were as same as the
information described in Aim 1 Methods except the expression of the gene of interest was
calculated as a percentage of GAPDH expression this time. The primer sequences except A2AR
and A2BR, which have been shown in Table 1, are listed in Table 3.
Table 3: Sequences of primers used in Aim 2.
Gene

Forward Primer Sequence 5’-3’

Reverse Primer Sequence 5’-3’

AT1R

AACAGCTTGGTGGTGATCGTC

CATAGCGGTATAGACAGCCCA

β2R

CCTCATGTCGGTTATCGTCC

GGCACGTAGAAAGACACAATC

GAPDH

TCTACATGTTCCAGTATGACTC

ACTCCACGACATACTCAGCACC

IL-1β

GCTAGGGAGCCCCCTTGTCGAG

AGGCAGGGAGGGAAACACACGTT

IL-6

TCCGCAAGAGACTTCCAGCCAG

TGTGAAGTAGGGAAGGCAGTGGC

G. Statistical analysis
Data were analyzed with GraphPad Prism software and are presented as means ± SE.
Signaling, collagen and cytokine expression were analyzed by one-way ANOVA. Statistically
significant differences were taken at p<0.05.
III Results
Although CF were isolated according to standard protocols and the medium was
exchanged twice in the first 24 hours to remove non-adherent and contaminating cells, it is very
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difficult to obtain pure cell isolations. Since non-fibroblasts, macrophages and other immune
cells, could contribute to our observations, we assessed the purity of our CF cultures. As shown
in Figure 15, DDR2 mRNA level were ~ 10 fold greater than the levels of the two immune cell
markers. These findings support the fidelity of our CF cultures.
Figure 15: Purity of cultured murine CF.
DDR2 (discoidin domain receptor 2): a
specific maker for CF; F4/80 is a
macrophage marker and CD11b is a marker
for macrophages and other immune cells.
Data are means ± SE, n = 3.

Figure 16 illustrates that murine CF exhibit considerable A2BR and A2AR gene
expression, with A2BR being approximately three-fold greater than that of A2AR. Little A1R and
A3R expression was observed (data not shown). Gene expression of A2BR was much greater than
that for adrenergic (R and A2AR expression was comparable to that of angiotensin
receptor type I subtype (AT1R).
Figure 16: Gene expression of
and
CF
adenosine,
β2R
angiotensin receptor type I
receptors (n=3). Results are Data
are means ± SE, expressed as
percentage of GAPDH.
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Activation of ERK is thought to play a role in CF collagen production (Chintalgattu and
Katwa, 2004; Liu et al., 2006; Gao et al., 2009), and adenosine receptor agonist effects on ERK
phosphorylation are shown in Figure 17. Representative blots of phospho-ERK and total ERK
are shown in Figure 17A. Figure 17A also indicated that the CGS-mediated increase in ERK
phosphorylation was abolished by deletion of the A2AR.

Additionally the BAY-mediated

increase in ERK phosphorylation was blocked by the selective A2BR antagonist MRS1754 and in
A2BR KO CF. The effect of the non-selective agonist NECA on ERK activation was also
reduced, but not eliminated, by MRS1754. Figure 17B presents the summary results of p44 ERK
phosphorylation.

The A2BR agonist BAY and the A2AR agonist CGS increased ERK

phosphorylation 3.7 ± 0.4 and 5.3 ± 1.0 fold, respectively, vs. the Veh group (p < 0.05).

Figure 17: ERK phosphorylation following 10 min treatments with selective A2BR (BAY, 500
nM) and A2AR (CGS, 500 nM) agonists. The upper band shows the p44 ERK, and lower one
represents the p42 ERK. (A) Representative Western blots for CGS and BAY effects on ERK
phosphorylation in WT, A2AR and A2BR KO CF. Also shown are the effects of the A2BR
antagonist MRS1754 on NECA (5 M) and BAY effects in WT CF. (B) Quantified p44 pERK
relative to ERK (normalized to Veh), data were expressed as relative to Veh group, n = 7 for
BAY, n = 6 for CGS. Data are means ± SE. *p<0.05 vs. Veh.
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Both A2AR and A2BR couple to Gs proteins, resulting in increased cAMP levels and PKAdependent phosphorylation.

To determine the effects of selective A2AR and A2BR on this

signaling pathway, we assessed serine-133 phosphorylation of the cAMP response elementbinding protein (CREB).

As shown in Figure 18 both BAY and CGS increased CREB

phosphorylation (29.7 ± 8.7 fold and 5.7 ± 0.9 fold for BAY and CGS, respectively, p < 0.05 vs.
Veh). These effects were significantly reduced by the PKA inhibitor H89 (7.3 ± 2.4 fold for
BAY, 2.8 ± 0.6 fold for CGS).

Figure 18: Effects of BAY and CGS on CREB phosphorylation in the absence and presence of
the PKA inhibitor H89 (5 µM). CF were treated as described in Figure 16; H89 was
administered 30 min prior to the agonists. The molecular weight (MW) of CREB is 43 kDa. (A)
Representative Western blots. (B) Quantification of pCREB relative to CREB, normalized to
Veh. n ≥ 4 per group. Data are means ± SE. *p<0.05 vs. Veh.
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Increases in cAMP typically inhibit collagen synthesis, thus we determined the effects of
adenosine receptor agonists on TGFβ-induced collagen-1 expression. As illustrated in Figure 19,
TGFβ increased collagen-1 expression 2.1 ± 0.4 fold compared with Veh treatment (p < 0.05).
None of the adenosine receptor agonists altered the TGFβ effects on collagen (3.0 ± 1.0 fold
increase for BAY, 3.1 ± 1.0 fold for CGS and 2.3 ± 1.9 fold for NECA).

Figure 19: Collagen-1 expression in CF treated with TGF (10 ng/mL) with or without BAY
(500 nM), CGS (500 nM) and NECA (5 M) for 24 h. MW of collagen-1 is about ~ 130 kDa.
(A) Representative Western blots for collagen-1 and tubulin. (B) Fold increase in collagen-1
expression relative to Veh group with TGF n ≥ 4 per group. Data are means ± SE. *p<0.05 vs.
Veh.
Since stimulation of A2BR and A2AR did not decrease collagen expression induced by
TGFβ, we assessed the effects of these receptor agonists alone on collagen-1 expression (Figure
20). Representative blots of collagen-1 and tubulin are shown in Figure 20A. Both BAY and
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CGS significantly increased collagen-1 production compared to the Veh group (2.3 ± 0.3 fold for
BAY, 2.2 ± 0.3 fold for CGS, p < 0.05). The non-selective adenosine receptor agonist NECA
increased collagen-1 levels 2.6 ± 1.1 fold (p < 0.05 vs Veh) (Figure 20B).
Figure 20: Adenosine receptor
agonist effects on collagen-1
expression. The effects of selective
A2AR and A2BR stimulation were
assessed in the presence and
absence of the PKA inhibitor H89
(5 µM) and the MEK inhibitor
U0126 (10 µM). (A) Representative
Western blots for collagen-1 and
tubulin. (B) Summarized collagen-1
results expressed relative to Veh
group (n = 6-9 per group). Data are
means ± SE. *p<0.05 vs. Veh.

Since BAY and CGS stimulated ERK phosphorylation, and ERK activation appears to
play a key role in CF collagen production (Chintalgattu and Katwa, 2004; Liu et al., 2006; Gao et
al., 2009), we tested the effects of the MEK inhibitor U0126 on adenosine receptor-mediated
increases in collagen. PKA inhibition has been reported to block adenosine A2AR-induced
collagen production in fibroblasts (Che et al., 2007; Perez-Aso et al., 2013b), thus we also tested
the effects of the PKA inhibitor H89 on CF collagen expression. As shown in Figure 20B the
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ability of selective A2BR and A2AR agonists to increase CF collagen levels is significantly
reduced by both U0126 and H89.
Acute stimulation of A2AR and A2BR is associated with anti-inflammatory effects
(Bshesh et al., 2002; Antonioli et al., 2014). Additional reports indicate that activation of A2BR
can also promote pro-inflammatory cytokine production (Ryzhov et al., 2006; Wilson et al.,
2011). Thus, we assessed gene expression of IL-1 and IL-6 in WT CF (Figure 21). Neither
agonist showed altered IL-1 gene expression, but BAY (2.4 ± 0.1 fold), not CGS, significantly
increased IL-6 mRNA levels.

Figure 21: Selective A2BR and A2AR agonist effects on pro-inflammatory cytokine gene
expression. Treatment conditions were identical to the conditions described in Fig. 18 and 19.
Cytokine expression was normalized to percentage of GAPDH. Data are means ± SE. *p<0.05
vs. Veh. n > 3 per group.
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CHAPTER 4: DISCUSSION
I. Summary
A summary of the important findings is listed below:
1. A2BR gene expression in the scar region increased significantly in the 5-day post-MI WT
heart, a time that is associated with significant inflammation.
2. Ablation of A2BR decreased TNF- and MMP-9 gene expression in the 5-day infarct
zone, consistent with decreased inflammation.
3. At 28-days post-MI A2BR KO hearts exhibited increased scar thickness and decreased
infarct expansion.
4. Deletion of A2BR deceased macrophages infiltration and collagen deposition in remote
zone of 28-day post-MI heart, but did not downregulate myofibroblast expression.
5. A2BR and A2AR are highly expressed in adult murine CF.
6. Selective activation of both A2BR and A2AR increased ERK and CREB phosphorylation.
7. Both Gs coupled adenosine receptors failed to inhibit TGF-induced collagen-1
expression.
8. Stimulation of A2BR and A2AR alone increased collagen expression, effects that were
significantly blunted by MEK and PKA inhibitors.
9. Activation of A2BR, but not A2AR, increased IL-6 gene expression.
II. Contrasting roles of A2BR in acute and chronic ischemic myocardium
Although A2BR are the least characterized of the four adenosine receptor subtypes
expressed in the heart, there are multiple reports that A2BR agonist stimulation is cardioprotective
in the setting of acute myocardial ischemia-reperfusion injury (Kuno et al., 2007; Xi et al., 2009;
Methner et al., 2010). Such studies also indicate that treatment with A2BR antagonists or deletion
of A2BR does not exacerbate acute injury (Maas et al., 2010; Methner et al., 2010; Zhan et al.,
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2011). However the few studies examining the role of A2BR in chronic models of MI are
contradictory. Results from one group suggested that long-term stimulation of A2BR decreased
post-MI remodeling and fibrosis (Wakeno et al., 2006), whereas two more recent studies
indicated that A2BR blockade reduced adverse cardiac remodeling (Toldo et al., 2012; Zhang et
al., 2013). Our current findings support the latter two studies indicating that A2BR contribute to
adverse remodeling in the chronic post-MI heart.
III. Pro-inflammatory effects of A2BR in post-MI heart
One of our initial findings was that A2BR mRNA was significantly increased in the scar
zone of 5-day WT post-MI hearts compared to the remote zone. A2BR are highly expressed on
immune cells, such as macrophages, dendritic cells and regulatory T cells (Kreckler et al., 2006;
Wilson et al., 2011; Ehrentraut et al., 2012), and macrophage infiltration in the infarct zone peaks
on days 4-5 (Yang et al., 2002; Naresh et al., 2012). Thus the increase in scar zone A2BR
expression may be due to the increase in immune cell infiltration and proliferation. In addition
A2BR are upregulated in immune cells under inflammatory conditions (Chen et al., 2009; RuizGarcia et al., 2011). Our observations that A2BR are upregulated in the infarct zone within days
after MI, and A2BR deletion is associated with increased scar thickness, decreased infarct
expansion, and reduced collagen deposition in remote zone support the hypothesis that increased
A2BR signaling contributes to adverse post-MI remodeling. In contrast to A2BR, A2AR gene
expression tended to decrease in the early post-MI period. A recent report indicated that A2AR
expression in macrophages was down-regulated by low molecular weight fragments of
hyaluronan (Collins et al., 2011), a component of the extracellular matrix, and hyaluronan levels
have been reported to increase in within days of an MI (Waldenstrom et al., 1991).
One of the possible explanations for the decreased remodeling in A2BR KO hearts could
be decreased post-MI inflammation. Deletion of A2BR significantly decreased 5 day post-MI
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expression of TNF- and MMP-9, both of which have been reported to increase after MI and
contribute to remodeling (Heymans et al., 1999; Ducharme et al., 2000; Peterson et al., 2000;
Ramani et al., 2004; Sun et al., 2004; Monden et al., 2007). It has also been reported that TNF-
induces MMP-9 upregulation in multiple cell types, including monocytes and macrophage
(Vaday et al., 2001; Li et al., 2006).

Our findings are consistent with reports that A2BR

stimulation is associated with pro-inflammatory cytokine production in several cell types,
including CF (Ryzhov et al., 2006; Feng et al., 2010; Wilson et al., 2011). In addition selective
A2BR antagonists have been shown to significantly inhibit pulmonary inflammation, and deletion
of A2BR (whole animal and myeloid cell-specific) has also been reported to decrease chronic
inflammation (Sun et al., 2006; Mustafa et al., 2007; Belikoff et al., 2011; Belikoff et al., 2012).
Our observations are the first report of the effects of A2BR deletion in a chronic post-MI model.
IV. Comparison of our results with other reports
Deletion of A2BR had no effect on infarct size but did increase scar thickness and
decrease infarct expansion at 28 days post-MI. A thicker scar has been shown to increase postMI cardiac function (Dai et al., 2005), whereas infarct expansion into the border zone
exacerbates wall thinning and ventricular dilation (McKay et al., 1986; Pfeffer and Braunwald,
1990). The finding that A2BR deletion did not alter infarct size, which is consistent with previous
observations in acute MI models (Maas et al., 2010; Methner et al., 2010; Zhan et al., 2011),
indicates that A2BR KO reduced adverse post-MI remodeling. Our results are also consistent
with two previous reports in models of chronic myocardial ischemia using a selective adenosine
A2BR antagonist (Toldo et al., 2012; Zhang et al., 2013). Toldo et al. (Toldo et al., 2012) first
reported that the administration of GS-6201 immediately following a permanent occlusion and
continuing for 14 days resulted in a thicker scar, less LV hypertrophy and improved post-MI
cardiac function in mice after 4 weeks. This group reported that GS-6201 treatment significantly

42
decreased plasma levels of IL-6 and TNFα at 28 days post-MI, but did not measure collagen. In
contrast we measured infarct and remote zone inflammation at 5 days and collagen deposition in
the remote zone at 28 days. In a chronic occlusion-reperfusion model in rats, the same A2BR
antagonist administered at one week post-MI reduced fibrosis and improved ventricular function
(Zhang et al., 2013). Conversely, Wakeno et al. (Wakeno et al., 2006) concluded that long term
stimulation of A2BR protected the heart against MI. However these authors administered a nonselective adenosine receptor agonist one week after the MI, and the effect of an A2BR antagonist
alone was not tested (Wakeno et al., 2006).
A2BR KO hearts exhibited decreased collagen-1 and 3 gene expression in the remote zone
of 5-day post-MI and less collagen deposition in the remote zone at 4 weeks. It has been well
documented that excess collagen increases myocardial stiffness and decreases cardiac function
(Jalil et al., 1989; Litwin et al., 1991). Our observations in A2BR KO hearts are consistent with
those of Toldo et al. (Toldo et al., 2012) and Zhang et al. (Zhang et al., 2013) who reported that
post-MI treatment with a selective A2BR antagonist increased ventricular function and reduced
interstitial collagen content, respectively. Our findings are also consistent with reports that A2BR
contribute to fibrosis in other organs (Sun et al., 2006; Dai et al., 2011). The reduced collagen
expression in 28 day post-MI remote zones of A2BR KO hearts did not appear to be due to
decreased myofibroblast expression, however this could be due to reduced macrophage
infiltration in the remote zone, since macrophages play an important role in cardiac fibrosis
(Nian et al., 2004; Lee et al., 2012; Nahrendorf and Swirski, 2013).
The present findings in the whole animal KO as well as the observations with selective
A2BR antagonists indicate that A2BR modulate cardiac remodeling independent of infarct size
(Toldo et al., 2012; Zhang et al., 2013). These results differ from those of Ryzhov et al. (Ryzhov
et al., 2013), who reported that injection of WT stem cells into the peri-infarct area of
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permanently occluded mouse hearts increased post-MI ventricular function, a beneficial effect
that was absent when using A2BR KO stem cells. However an important difference in the study
by Ryzhov et al. (Ryzhov et al., 2013), is the fact that their intervention significantly decreased
infarct size.

Thus the presence of A2BR on a small population of cells may play a

cardioprotective role in the very early period following an MI.
Deletion of A2BR reduced levels of TNF- and MMP-9 in the early post-infarct period
consistent with decreased inflammation, and this was associated with less adverse remodeling.
The reduced fibrosis in A2BR KO post-MI hearts at 28 days could be due to lower inflammation
and/or improved healing. However since A2BR are highly expressed on CF, the beneficial effects
of A2BR deletion could be due, in part, to direct effects on CF.
V. Effects of selective adenosine A2BR and A2AR activation in CF
One of our most important observations is that stimulation of A2BR alone, under serumfree conditions, increased collagen expression. There is significant evidence that stimulation of
A2BR are associated with increased fibroblast collagen synthesis and organ fibrosis (Sun et al.,
2006; Feng et al., 2010; Wen et al., 2010; Dai et al., 2011; Karmouty-Quintana et al., 2012;
Zhang et al., 2013). However, the results of existing CF studies suggest that A2BR stimulation
decreases collagen synthesis (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004; Wakeno
et al., 2006; Villarreal et al., 2009). The deficiency in CF studies examining the role of A2BR is
the use of non-selective agonists, such as NECA and 2-chloroadenosine. High concentrations
(μM) of NECA are needed to activate low affinity A2BR, but nM doses of NECA activate high
affinity A2AR. Our current findings that A2BR and A2AR are both expressed in CF, with A2BR
mRNA levels being two-fold greater than that of A2AR, are similar to observations in rat CF
(Epperson et al., 2009). Given the significant A2AR expression in CF, results obtained with
NECA cannot be attributed exclusively to A2BR. Our observations thus provide the first report
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of selective A2BR activation in CF. The agonist BAY 60-6583 is a relatively new, highly
selective agonist for mouse A2BR (Auchampach et al., 2009). The A2BR selectivity of BAY in
the present study is supported by the observations that the signaling effects of this agonist were
blocked by the A2BR antagonist MRS1754 and by deletion of A2BR. Likewise, the effects of the
well-characterized A2AR agonist CGS were blocked by deletion of A2AR.
Interestingly Chen et al. (Feng et al., 2010) reported that although non-selective A2BR
activation slightly decreased serum-induced increases in collagen in rat CF, this same treatment
increased collagen synthesis after A2BR overexpression. In addition a recently published report
indicates that NECA (10 µM) increased collagen expression in human CF, an effect that was
completely blocked by a selective A2BR antagonist (Zhang et al., 2013). In contrast Villarreal et
al. (Villarreal et al., 2009) demonstrated that NECA alone did not alter collagen expression under
serum-free conditions. Our observations with both high concentrations of NECA and the A2BR
selective agonist BAY indicate that A2BR stimulation increases collagen in mouse CF. Our
observations that selective A2BR stimulation increased CF collagen are consistent with findings
in corpus cavernosal fibroblasts (Wen et al., 2010).
Our data also showed that stimulation of A2AR also promote mouse CF collagen
expression. This observation is consistent with the results of A2AR studies in dermal and hepatic
stellate cells (Chan et al., 2006a; Che et al., 2007; Chan et al., 2013; Perez-Aso et al., 2013a). In
contrast to studies in other types of fibroblasts, findings in rat CF indicated that A2AR exerted
little, if any, effect in collagen synthesis, although the selective A2AR agonist, CGS, was used in
those studies (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004). The discrepancy
between our and their studies cannot be explained by any reason other than specie difference.
It is well recognized that A2BR and A2AR are Gs protein-coupled receptors, whose
stimulation results in increased cAMP accumulation. Our results support this signaling pathway

45
in mouse CF as both A2BR and A2AR stimulation increased CREB phosphorylation, and these
effects were blunted by the PKA inhibitor H89. These findings are consistent with the reports of
A2BR and A2AR effects on cAMP and/or CREB in various types of fibroblasts (Liu et al., 2006;
Liu et al., 2008; Villarreal et al., 2009; Perez-Aso et al., 2013a). Both high concentration NECA
and CGS increased cAMP accumulation in rat CF with A2BR being more efficacious than A2AR
(Epperson et al., 2009). Similarly we observed that A2BR stimulation tended to increase CREB
phosphorylation to a greater extent than did A2AR. These effects could be due to the two-fold
greater expression of A2BR.

Feng et al. (Feng et al., 2010)reported that NECA, at a

concentration of 1 µM, which should have activated both A2BR and A2AR, had no effect on
cAMP in murine CF.
Despite our evidence supporting A2BR and A2AR coupling to Gs, stimulation of neither
receptor decreased TGFβ-induced increases in collagen, as has been reported for β-adrenergic
receptors in rat CF (Liu et al., 2006). These results also conflict with previous studies in rat CF
in which high concentrations of NECA (supportive of a role for A2BR) decreased collagen
synthesis induced by fetal calf serum (Dubey et al., 1998; Dubey et al., 2001; Chen et al., 2004)
and angiotensin (Villarreal et al., 2009). Our study appears to be the first to examine the effects
of selective A2BR stimulation on CF collagen production, and it is possible that these differences
could be due to the use of selective vs. non-selective agonists, species differences, and or
collagen-inducing stimuli. The lack of effect of CGS on TGFβ-induced increases in collagen is
consistent with reports that A2AR exerts little, if any, effect on CF collagen (Dubey et al., 1998;
Dubey et al., 2001; Chen et al., 2004). In fact Chen et al. (Chen et al., 2004), using NECA and
CGS, could not differentiate between the roles of A2BR and A2AR on collagen synthesis in rat
CF. The effects of BAY on ERK phosphorylation are consistent with previous findings in rat CF
based on results obtained with a high concentration of the non-selective agonist NECA
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(Epperson et al., 2009), however the effects of selective A2AR activation on ERK activation in
CF have not been previously reported. Our results indicate that selective A2AR and A2BR
stimulations both increased ERK phosphorylation, and the effects of NECA on ERK
phosphorylation were only partially blunted with MRS1754, consistent with a role for A2AR.
Selective A2AR stimulation has been reported to increase ERK activation in human hepatic
stellate cells (Che et al., 2007) and human dermal fibroblasts (Chan et al., 2006a). In contrast to
our observations, Feng et al. (Feng et al., 2010) reported that NECA (1 µM) did not alter ERK
phosphorylation in mouse CF. We cannot explain the differences between our findings and
those of Feng et al. (Feng et al., 2010), since 1 µM NECA should have stimulated both A2AR and
A2BR, and we observed that activation of both receptors increased ERK phosphorylation.
Our observations also indicate that A2BR and A2AR-induced increases in collagen are
mediated via ERK- and PKA-dependent pathways. The inhibition of adenosine receptor-induced
collagen expression with the MEK inhibitor, U0126, is consistent with several reports that CF
collagen synthesis is ERK-dependent (Chintalgattu and Katwa, 2004; Liu et al., 2006; Gao et al.,
2009). Epperson et al. (Epperson et al., 2009) reported that adenosine receptor stimulation with
NECA increased ERK phosphorylation in rat CF, but the effects of selective A2BR and A2AR
agonists were not determined. The same group also reported that NECA decreased angiotensininduced collagen production via an ERK-independent pathway (Villarreal et al., 2009). Our
findings that A2AR-induced increases in collagen appeared to be ERK-dependent are consistent
with reports that U0126 inhibited CGS-induced collagen production in human dermal fibroblasts
and human hepatic stellate cells (Chan et al., 2006a; Che et al., 2007).
It is well known that A2BR and A2AR are coupled to Gs proteins, whose stimulation
results in increased cAMP levels, and GPCR-induced increases in cAMP are generally
associated with decreases in collagen synthesis (Dubey et al., 2001; Liu et al., 2006; Liu et al.,
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2008; Yokoyama et al., 2008; Villarreal et al., 2009). In the present study neither A2BR nor
A2AR stimulation decreased TGFβ-induced increases in collagen, and the PKA inhibitor, H89,
blocked the collagen increases associated with both receptor agonists. Although these findings
appear paradoxical for Gs coupled receptors, the role of the cAMP-PKA pathway in modulating
collagen levels is complex. It has been reported that in human dermal fibroblasts forskolin
decreased collagen expression, whereas A2AR stimulation increased collagen expression (PerezAso et al., 2013a). These paradoxical findings appear to be due to the 100-fold greater increase
in cAMP induced with forskolin compare to the effect of CGS. Likewise the β receptor agonist
isoproterenol has been shown to produce a much greater increase in rat CF cAMP levels than
NECA (Liu et al., 2008; Epperson et al., 2009), and isoproterenol exerts much greater decreases
in CF collagen production than does NECA (Liu et al., 2008).
VI. Effects of selective adenosine A2BR and A2AR activation on CF cytokine production
Although both A2AR and A2BR have been reported to exert anti-inflammatory effects
(Bshesh et al., 2002; Antonioli et al., 2014), A2BR activation can also induce pro-inflammatory
cytokine production (Ryzhov et al., 2006; Wilson et al., 2011). Our results indicate that selective
A2BR stimulation increased pro-inflammatory IL-6, but not IL-1gene expression, whereas
activation of A2AR exerted no effects. It is well accepted that the A2AR anti-inflammatory effect
is mediated via Gs coupling (Bshesh et al., 2002; Antonioli et al., 2014). In contrast A2BR
stimulation promotes IL-6 production independent of Gs coupling to cAMP (Ryzhov et al.,
2008a; Wilson et al., 2011). Our observations are consistent with those of Feng et al. (Feng et
al., 2010), who reported that non-selective A2BR stimulation increased IL-6 production through a
Gq-PLC pathway in murine CF. However these authors reported that the EC50 for NECA effects
on IL-6 was ~ 150 nM, which is considerably lower than expected of the low affinity A2BR. Our
findings suggest that A2BR may exert its effects in murine CF via coupling to both Gs and Gq. In
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fact, Ryzhov et al. (Ryzhov et al., 2008a) concluded that A2BR exerted its effects in human mast
cells via Gs-Gq crosstalk. Our findings of A2BR-induced increases in collagen and IL-6 are
consistent with reports that A2BR appear to mediate adverse remodeling and fibrosis in post-MI
myocardium (Toldo et al., 2012; Zhang et al., 2013).
VII. Limitations
Although A2BR studies were conducted in both in vivo and in vitro preparations there are
some limitations to these studies which are described below.
1. We used semi-quantitative RT-PCR approach to evaluate the gene levels of multiple
types of proteins in both in vivo and in vitro studies. It would be helpful if the protein
levels and activities (such as MMP-9 activity zymography analysis) could have been
measured, since gene expression may not be proportional to the final protein expression.
In fact, we tried different A2BR antibodies from various companies, but none of them
worked. So we had to use RT-PCR to assess A2BR gene level instead of protein
expression.
2. Although one of the strengths of our studies is the use of whole animal adenosine A2BR
KO mouse, this approach is also one of the limitations. A2BR are highly expressed on
multiple immune cells and CF, which both contribute to post-MI repair and remodeling.
Thus we are not able to determine a cell-specific role for A2BR effects.
3. Our data would be stronger if we had cardiac functional measurements in our post-MI
remodeling studies.
4. Lack of sham animals limits conclusions regarding the true effects of A2BR deletion in
the remote zone.
VIII. Summary and conclusions
Our in vivo results indicated that MI induced increases in A2BR gene expression in the
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infarct zone of WT hearts at 5-days post-MI, and A2BR KO hearts exhibited decreased TNF-α
and MMP-9 mRNA levels at the same time point. WT post-MI hearts also exhibited higher
collagen-1 and -3 gene expression in the 5-day remote zone. Morphological analysis indicated
that A2BR deletion was associated with increased scar thickness, decreased infarct expansion, and
less remote zone macrophage infiltration and collagen deposition at 28-days post- MI. In vitro
studies indicated that A2BR and A2AR are highly expressed in murine CF, and both A2 subtypes
increased collagen-1 production via MEK and PKA pathways. However, only A2BR activation
increased expression of the pro-inflammatory cytokine IL-6. These observations suggest that
A2BR contribute to adverse remodeling and cardiac fibrosis after chronic MI, and the detrimental
role from the receptor could be due to its pro-inflammatory and pro-fibrotic effects in CF in this
chronic pathological process.
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Adenosine A2B receptor (A2BR) appear to contribute to chronic inflammation. This
receptor is highly expressed in macrophages and cardiac fibroblasts, cells which play key roles in
inflammation and healing following myocardial infarction (MI). A2BR have been shown to
induce collagen production and promote organ fibrosis, although the reports of A2BR role on MI
are limited and conflicting. The results of cardiac fibroblast (CF) studies however suggest that
non-selective A2BR stimulation inhibits collagen expression. The hypothesis of the present study
was that deletion of A2BR reduces adverse remodeling in post-MI, and selective activation of
A2BR increases WT murine CF collagen and pro-inflammatory cytokines production.
In our in vivo studies, MI was induced by permanent coronary artery occlusion in male
WT and A2BR KO mice. Hearts were harvested at 5 or 28-day post-MI for semi quantitative RTPCR assay or sectioned and stained for morphological and histological studies.

In CF

experments, effects of selective A2BR (BAY 60–6583, BAY) and A2AR (CGS-21680, CGS)
agonists on signaling (10 min) and collagen expression (24 h) were assessed by Western blots.
Adenosine receptor expression and agonist effects (24 h) on pro-inflammatory cytokine
expression were analyzed with semi-quantitative real time PCR.
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Mortality of total animals and 28-day infarct size did not differ between genotypes. A2BR
expression was 2.7 fold greater in WT scar zone compared to remote zone. TNF- and MMP-9
expressions in the scar zone and collagen 1 and 3 mRNA levels in the remote zone were much
greater in 5-day WT group without any change in macrophage infiltration. A2BR KO hearts had
greater scar thickness and lower infarct expansion. Our results indicated that ablation of A2BR
significantly decreased collagen deposition in 28-day post-MI remote zone. We also found that
this effect was not due to downregulation of myofibroblasts but related to decreased macrophage
infiltration at 28-day. Our results from CF studies indicated that A2BR gene expression was twofold greater than A2AR, which was comparable to angiotensin AT1R. The A2BR agonist BAY
and the A2AR agonist CGS both increased ERK and CREB phosphorylation. BAY and CGS
effects on signaling were blocked by deletion of A2BR and A2AR, respectively. TGF-induced
increases in collagen-1 expression were not altered by adenosine receptor agonists; in contrast,
selective A2BR and A2AR stimulation increased collagen-1 expression, effects which were
blunted by MEK (U0126) and PKA (H89) inhibitors. BAY, but not CGS, increased IL-6 gene
expression, but neither agonist showed an effect on IL-1 mRNA levels.
Our findings that a large increase in expression of the pro-inflammatory A2BR occurs in
the WT scar zone, and that A2BR deletion reducing adverse post-MI heart remodeling in both
scar and remote zones, suggest a detrimental role for A2BR in this chronic pathological process,
which could be, at least partially, through the effects on CF collagen and pro-inflammatory
cytokine production.
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